Catch the surprising rise of prediabetes in young adults and learn how primary care, sustainable lifestyle changes, and ...

Researchers in Boston are working to determine if an old tuberculosis vaccine could be the key to treating type 1 diabetes.

The results of a late-stage drug trial released Thursday are raising hopes that type 1 diabetes patients with chronic kidney ...

Hospitalized patients with diabetes require specialized management to reduce readmission rates and complications. Newer ...

As the Center for Medicare and Medicaid Innovation moves forward with additional drug-focused models, our Part D Senior ...

Scientists warn common diabetes drug may be cancelling out benefits of exercise - New study raises urgent questions about how ...

In a large real-world analysis across three U.S. healthcare databases, semaglutide and tirzepatide showed cardiovascular benefits consistent with randomized trials. Semaglutide lowered heart attack ...

Living with diabetes doesn’t have to mean accepting a lifetime of increasing medication doses and constant worry about blood sugar spikes. While traditional medical approaches focus heavily on ...

Diabetes drugs such as semaglutide already have a reputation for lowering the risk of cardiovascular events in people with ...

The study found that while sitagliptin does not prevent major heart problems like heart attacks or strokes, it may help limit damage to small blood vessels.

Rutgers researchers have discovered that a popular diabetes drug may reduce the health benefits people expect from it. A commonly prescribed medication for diabetes might actually be working against ...

The authors said: “T2D remission is not rare after initiation GLP-1RA, its frequency and duration varying by definition. When ...